Skip to main content
. 2010 Jul 29;15(8):799–809. doi: 10.1634/theoncologist.2009-0029

Table 2.

Characteristics of patients at initiation of trastuzumab treatment

graphic file with name onc00810-0611-t03.jpg

aDefined as time from breast cancer diagnosis to metastatic disease.

bLiver and/or lung and/or CNS.

Abbreviations: CNS, central nervous system; ER, estrogen receptor; HER-2, human epidermal growth factor receptor 2; IHC, immunohistochemistry; NA, not available; PgR, progesterone receptor.